SEC Filing Summary: SMI Products, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by SMI Products, Inc. (not Capricor Therapeutics, Inc.) on November 6, 2006, reporting events occurring on October 31, 2006. The filing addresses a change in the company's independent certifying accountants.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on auditor changes and does not contain financial performance data.
Material Changes
- Auditor Dismissal: The Board of Directors dismissed Amisano Hanson Chartered Accountants, who had served as principal accountant since 1996.
- New Engagement: The company engaged Paritz & Co. of Hackensack, NJ, as the new independent principal accountant and auditor for the fiscal year ended December 31, 2006.
- Reason for Change: The change is classified as a dismissal under Item 304 of Regulation S-K.
Outlook, Risks, and Management Commentary
Management confirmed there were no disagreements with the former auditor (Amisano Hanson) regarding accounting principles, financial statement disclosure, or auditing scope during the two most recent fiscal years or the interim period. Additionally, no reportable events occurred during the two most recent fiscal years. The company did not consult with the new auditor (Paritz & Co.) regarding any matters described in Item 304(a)(2)(i) or (ii) prior to the engagement.
Key Facts for Investor Verification
- Verify the reason for the dismissal of Amisano Hanson Chartered Accountants despite the stated lack of disagreements.
- Review the letter from Amisano Hanson (Exhibit 23.1) to confirm their agreement with the company's statements regarding the dismissal.
- Confirm the qualifications and independence of the new auditor, Paritz & Co.
- Note the discrepancy between the metadata company name (Capricor Therapeutics) and the actual registrant (SMI Products, Inc.).